Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:21357675  

Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A.

Todd S Macfarlan | Wesley D Gifford | Saurabh Agarwal | Shawn Driscoll | Karen Lettieri | Jianxun Wang | Shane E Andrews | Laura Franco | Michael G Rosenfeld | Bing Ren | Samuel L Pfaff
Genes & development | 2011

Endogenous retroviruses (ERVs) constitute a substantial portion of mammalian genomes, and their retrotransposition activity helped to drive genetic variation, yet their expression is tightly regulated to prevent unchecked amplification. We generated a series of mouse mutants and embryonic stem (ES) cell lines carrying "deletable" and "rescuable" alleles of the lysine-specific demethylase LSD1/KDM1A. In the absence of KDM1A, the murine endogenous retrovirus MuERV-L/MERVL becomes overexpressed and embryonic development arrests at gastrulation. A number of cellular genes normally restricted to the zygotic genome activation (ZGA) period also become up-regulated in Kdm1a mutants. Strikingly, many of these cellular genes are flanked by MERVL sequences or have cryptic LTRs as promoters that are targets of KDM1A repression. Using genome-wide epigenetic profiling of Kdm1a mutant ES cells, we demonstrate that this subset of ZGA genes and MERVL elements displays increased methylation of histone H3K4, increased acetylation of H3K27, and decreased methylation of H3K9. As a consequence, Kdm1a mutant ES cells exhibit an unusual propensity to generate extraembryonic tissues. Our findings suggest that ancient retroviral insertions were used to co-opt regulatory sequences targeted by KDM1A for epigenetic silencing of cell fate genes during early mammalian embryonic development.

Pubmed ID: 21357675

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: R01 NS034934
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK039949
  • Agency: Howard Hughes Medical Institute, United States

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


B6;129-Gt(ROSA)26Sortm1(cre/ERT)Nat/J (organism)

RRID:IMSR_JAX:004847

Mus musculus with name B6;129-Gt(ROSA)26Sortm1(cre/ERT)Nat/J from IMSR.

View all literature mentions

STOCK Edil3Tg(Sox2-cre)1Amc/J (organism)

RRID:IMSR_JAX:004783

Mus musculus with name STOCK Edil3Tg(Sox2-cre)1Amc/J from IMSR.

View all literature mentions

BayGenomics ES cell line RRK075 (organism)

RRID:MMRRC_003245-UCD

Mus musculus with name BayGenomics ES cell line RRK075 from MMRRC.

View all literature mentions